You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triplet

Showing 26 - 50 of 375
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Friedreich Ataxia Trial (friedreich Ataxia)

Not yet recruiting
  • Friedreich Ataxia
  • friedreich Ataxia
  • (no location specified)
May 23, 2023

Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Los Angeles, California
  • +24 more
Aug 10, 2022

Hypercholesterolemia Trial in United States (Bempedoic acid 180mg, Ezetimibe 10mg, Atorvastatin 20mg)

Completed
Has Results
  • Hypercholesterolemia
  • Bempedoic acid 180mg
  • +3 more
  • Champaign, Illinois
  • +10 more
Mar 20, 2020

C-staged Hepatocellular Carcinoma in BCLC Classification Trial in Guangzhou (Hepatic Arterial Infusion combined with Apatinib

Recruiting
  • C-staged Hepatocellular Carcinoma in BCLC Classification
  • Hepatic Arterial Infusion combined with Apatinib and Camrelizumab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 3, 2022

Newly Diagnosed Multiple Myeloma Trial in France (MLN9708, Lenalidomide, Dexamethasone)

Unknown status
  • Newly Diagnosed Multiple Myeloma
  • Bordeaux, France
  • +9 more
Feb 18, 2020

Metastatic Colorectal Cancer Trial in Japan (Oxaliplatin (L-OHP), Irinotecan HCl hydrate (CPT-11), Continuous intravenous

Completed
  • Metastatic Colorectal Cancer
  • Oxaliplatin (L-OHP)
  • +4 more
  • Matsuyama-city, Ehime-prefecture, Japan
  • +6 more
Jun 16, 2020

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

Active, not recruiting
  • Breast Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
  • +7 more
  • Birmingham, Alabama
  • +26 more
Dec 21, 2022

Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Pancreatic Adenocarcinoma Metastatic
  • Scottsdale, Arizona
    Clinical Trials Nurse Navigator
Oct 3, 2023

HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)

Not yet recruiting
  • HR+/HER2-negative Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Jul 7, 2022

Fuchs' Corneal Endothelial Dystrophy in France.

Completed
  • Fuchs Endothelial Corneal Dystrophy
  • Collection of datas
  • +2 more
  • Saint-Étienne, France
    Chu Saint-Etienne
Dec 29, 2021

Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023

Metastatic Colorectal Cancer Trial in Montpellier (bevacizumab, oxaliplatin and 5FU combination, Bevacizumab, oxaliplatin and

Terminated
  • Metastatic Colorectal Cancer
  • bevacizumab, oxaliplatin and 5FU combination
  • Bevacizumab, oxaliplatin and raltitrexed combination
  • Montpellier, France
    Val d'Aurelle Cancer Institute
Dec 24, 2019

Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC:

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • transarterial therapies
  • (no location specified)
Nov 27, 2022

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed
  • Gastric Cancer in Situ
  • +2 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022

Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)

Not yet recruiting
  • Soft Tissue Sarcoma
  • ADI PEG20
  • Placebo
  • (no location specified)
Jan 31, 2023

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022

Broad Solid Tumor Trial in Worldwide (BMS-986207, Nivolumab, Ipilimumab)

Recruiting
  • Broad Solid Tumor
  • Hackensack, New Jersey
  • +19 more
Jul 26, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022